Picture of Morphosys AG logo

MOR Morphosys AG Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapMomentum Trap

Annual cashflow statement for Morphosys AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

C2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-10397.9-514-151-190
Depreciation
Non-Cash Items-2.07-83.5201-174-126
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital17.811.8-178-51.99.83
Change in Accounts Receivable
Change in Other Assets
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-81.134.5-481-367-296
Capital Expenditures-3.67-49.3-26.2-15.2-2.87
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items83.1-830-80536018.2
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities79.5-880-83134515.4
Financing Cash Flow Items-1.015091,241315-11.4
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities0.3539071,32331143
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-1.1565.513.5279-244